Status message

Submissions for this form are closed.

AMIA 2013 Corporate Roundtable Registration

AMIA Corporate Roundtables are fully catered events hosted by organizations looking to engage directly with leaders in the field. Participation in Corporate Roundtables is voluntary and based on your interest in the topic and availability. These events allow you to provide feedback on corporate strategies, inform product development, and learn what important biomedical and health informatics issues these companies are exploring.

Please consider joining up to three roundtables from the registration list below.

At-a-Glance AMIA 2013 Corporate Roundtable

Monday, November 18, 7:00 A.M.

Booz Allen Hamilton

Topic: Connected Health Use Cases

Speakers: Juergen Klenk, PhD, Principal; Ernest Sohn, Lead Associate

Target Audience: CIOs, CMIOs, CQOs

Connected Health extends healthcare delivery beyond its traditional boundaries into our everyday lives through mobile technology, placing the patient, not the doctor, in the center. It relies heavily on the integration and analysis of patient generated data (e.g., from personal medical devices) and other healthcare data (e.g., electronic health records). It enables personalized delivery of the right information at the right time, including promotion of lifestyle changes for disease prevention, disease management (e.g., chronic care), patient management (e.g., prevention of hospital readmission, compliance), and early detection (e.g., warning signals). This Roundtable focuses on how Connected Health can support these use cases, allowing for an exchange of success stories, discussion of technical requirements, potential barriers, and solutions.

Monday, November 18, 12:00 P.M.

GE

Topic: Population Health Management: Key Challenges and Lessons Learned

Speaker: Rishi Saurabh

Target Audience: CIOs, CMIOs, CQOs

Is your organization focused on clinical decision making with advanced analytics and clinical data? Is data-driven evidence-based population health management and patient engagement a key priority for your organization? Population Health Management (PHM) is a key enabler for achieving the goal of accountable care – delivering greater value to patients through improved quality and reduced cost. Realizing this goal requires competencies in four key areas:

  1. Characterization of the clinical and financial risk of the covered population and predict these risks going forward
  2. Effective care management/intervention programs based on the risk profile/burden of the population and the projected cost of care are fundamental to delivering clinical and financial value
  3. Care intervention programs that support and enhance effectiveness of care management teams through near real time analytics
  4. Patient and stakeholder engagement

Given this context, in this roundtable session we will explore key challenges faced by your organization specifically as they relate to:

  • Aggregating and processing data
  • Risk stratification, prediction, and enabling analytics
  • Implementation bottlenecks
  • Organizational/cultural roadblocks

IMO

Topic: Building a Semantic Foundation: Accelerating Medical Informatics Innovation in the EHR Community and Market

Speakers: Frank Naeymi-Rad, PhD, MS, MBA, Chairman, CEO and Co-Founder of Intelligent Medical Objects; Andrew S. Kanter, MD, MPH, FACMI, Director of Clinical Integration of Intelligent Medical Objects; Regis Charlot, MS, President and Chief Technology Officer of Intelligent Medical Objects

Target Audience: Academic centers with medical informatics training programs, Care delivery research institutions with strong Informatics teams, EHR vendors, data analytics vendors, and decision support vendors focused on applications to support care outcomes.

This round table will focus on the software engineering foundations that have the potential to accelerate modeling, development and distribution of innovative medical informatics applications. We will discuss an application development platform that can enable and accelerate the distribution and monetization of ideas by systematically applying semantic standards to foster interoperability.

We hope to have an interactive session identifying some of the key challenges in the market that can benefit from standardized semantic representations and encourage a healthy and protective exchange of new ideas and potential discoveries.

The most important topics will be:

  • How can we bring value to innovators through semantic foundation appliances and tools?
  • How can we maximize the investment return to innovators and institutions?
  • How can we measure an initiative's success?
  • How can we identify stakeholders, remove barriers, improve odds of success, and transform obstacles to advantages?

Relevant examples will be emphasized:

  • Demonstration of the use of a Clinical Terminology foundation platform powering commercial EHR vendor applications, resulting in a Technology Leap in innovation and improved care.
  • Demonstration of an OpenMRS implementation featuring key innovative features for Interface Terminology implementation, and retrospective patient data collection.
  • Additional examples of free-standing applications leveraging the semantic foundation

Linguamatics

Topic: Advanced NLP for Electronic Health Records

Speakers: David Milward, Chief Technology Officer, Linguamatics; Simon Beaulah, Director, Healthcare Strategy

Target Audience: CIOs, CMIOs, Research Informatics, Bioinformatics, NLP & Text mining

The rapid growth of Electronic Health Records (EHRs) provides an amazing source of valuable data, with the potential to improve efficiency and patient outcomes. However, with up to 75% of the richest information trapped in unstructured text, hospitals and medical researchers need better ways to leverage this vital information. This round table discussion will look at how advanced NLP can be applied to a growing range of healthcare applications that enable data analysts and medical researchers to:

  • Extract valuable information from complex patient documentation such as radiology and pathology reports
  • Identify care gaps, for example in cardiovascular disease
  • Build predictive models of key areas such as re-hospitalization
  • Link EHR data to external sources such as Clinical Trials.gov to identify potential trials

MEDITECH

Topic: Business and Clinical Analytics for Physician Managers

Speakers: Jeffrey J. Kosowsky, MD, PhD

Target Audience: CMIOs, CMOs, CIOs, BCA subject experts, Clinical Informatics Leaders

At MEDITECH, our new Business and Clinical Analytics product provides healthcare managers and executives with the synthesized data and analytic tools they need to make actionable decisions that improve both the quality and economics of healthcare delivery. During the rountable discussion, we will outline how our integrated and comprehensive vision delivers on this promise and how it differs from other common third party approaches. We will then launch a group discussion around the most useful current and emerging clinical and financial metrics for physician managers, department heads, and CMOs/CMIOs

Tuesday, November 19, 7:00 A.M.

HP

Topic: Building a Health Informatics core in support of DoD and VA clients

Speakers: Omar Bouhaddou; Bo Dagnall; David Gilbertson

Target Audience: Government officials, Educators, CMIOs, CIOs, Professional Organizations, Students, and Health Administrators interested in creating a health informatics organizational capability or responsible for training our health informatics workforce.

We invite AMIA members to join us in a lively discussion on how the HP Military Health System (MHS) and Veterans Affairs (VA) Account has defined and conceptualized core health informatics capability in the context of relevant industry and government examples, and to discuss innovative ways to establish and mature an organizational informatics capability. As the Nation transforms healthcare through increased automation and more powerful tools for managing healthcare information, so too must the MHS and VA evolve. From providing seamless care to our wounded warriors to providing quality and cost effective care for an expanding number of beneficiaries, our clients demand Industry partners that understand the power of Health informatics. Health Informatics is a critical component of government and private health provider IT initiatives, including the VA and MHS efforts to independently modernize their EHRs while creating a “virtual integrated patient record”. Industry supporting the MHS and VA medical communities are being challenged to create a health informatics capability that is ready to respond to the emerging needs of our clients. Foundational to this capability is the ability to consistently and unambiguously define and scope health informatics, to understand its core components and how they relate to each other, and effectively apply them to the specific needs of our clients.

Velos

Topics: Opportunities for disruptive improvement in clinical research information infrastructure

Speakers: John McIlwain, CEO, Velos, Inc.; Ravi Gill, CEO, Comaiba, Inc.

Target Audience: CMIOs, Decision support subject matter experts, etc.

Comaiba is a Velos partner in clinical research. Comaiba’s namesake product helps healthcare organizations achieve and sustain operational excellence by optimizing the implementation, operationalization, and monitoring of standards and best practices. The solution has applications in patient care, clinical research, finance, and administration. Leading clinicians are calling Comaiba a potential game changer in driving better, more consistent, and more affordable health care. In this round table the companies will share Comaiba applications in patient care and clinical research including demonstrations and use cases. The session with then open up with the companies seeking input from participants on other potential high impact applications across the healthcare domain.

Tuesday, November 19, 12:00 P.M.

CAP Consulting

Topic: Maximizing the EHR’s Contribution to Clinical Intelligence

Speakers: Paloma Hawry, Managing Director, CAP Consulting, College of American Pathologists; Jason Mitchell, MD, VP, Chief Medical Information Officer, Presbyterian Healthcare Services

Target Audience: CMIO/CIO’s

Meaningful Use, quality reporting, and value-based medicine require measurable and reliable clinical information. Can your organization truly trust and rely on analytics derived from today’s electronic health records? CMIOs and CIOs are at the center of information management and strategy and are simultaneously managing demands for information, EHR upgrades and clinician adoption issues.

This roundtable will focus on today’s information challenges and how to implement a practical framework for clinical information optimization and clinical intelligence.

CAP Consulting will present some perspectives to stimulate the peer to peer discussion:

  • Clinical analytics and enterprise data challenges with specific examples
  • Building a framework for enterprise clinical information maturity and quality
  • Concurrent integration of data governance with EHR upgrade and change management
  • Getting enterprise buy-in for information optimization and data governance initiatives

Cerner

Topic: Population Health

Speaker: Bharat Sutariya

Target Audience: CMIO, CMO, Clinical Informatics Experts, Consumer Informatics Specialists, Health System Managed Care Experts

The topic of Population Health Management has become one of the most talked about in health care today. As more and more provider organizations are moving toward shared risk payment models, the demand for a comprehensive unified Population Health Management platform which included clinical, financial, claims and other data continues to grow. During this session, we are interested in hearing how you and your organization define Population Health, how you are managing risk today, where you are on the journey towards population health management and what you think the journey looks like for your organization in the future. How does your organization transition from aggregating data for only analytics purposes to be able to leverage big data to engage members and manage your populations? Are you using data to manage disease registries today or managing the total health of the individual? What would you expect from a comprehensive programmable platform integrated with ontology and evidence to provide true coordination across the continuum of care?

Deloitte/ Recombinant by Deloitte

Topic: Comprehensive Readmissions Management

Speakers: Matvey Palchuk, MD, MS, Specialist Leader, Recombinant By Deloitte; Michael Kamerick, Specialist Leader, Recombinant By Deloitte

Target Audience: CMIO's, etc

Join Recombinant By Deloitte for a roundtable discussion of the issues surrounding readmissions management. Our session will be led by Dr. Matvey Palchuk, CMIO for Recombinant By Deloitte. Dr. Palchuk will provide a conceptual overview of readmissions management and a framework for informing decisions about proper approaches to the issue. Readmissions management has become one of the hottest topics in the healthcare industry, due largely to the changes in reimbursement models brought about by the Affordable Care Act. Hospitals are facing both the opportunity and the liability for going at risk for the management of the health outcomes of a designated population of patients. Reducing readmissions in such populations will be a key factor in determining the success of value based care models, both for patients and for providers.

First Databank (FDB)

Topic: Medication CDS: Remedying Alert Fatigue Using Targeted Alerts and Outcomes

Speakers: Joan Kapusnik-Uner, Pharm.D., FASHP, FCSHP

Target Audience: CMIOs, Physicians, Pharmacists, Nurses, Informaticists – anyone involved in alert management related to drug information

This year, First Databank’s roundtable discussion explores strategies for implementing more targeted sets of alerts in lieu of an entire domain (e.g. QT prolongation warnings rather than all drug-disease warnings). A key focus of the session will be on ways to target the negative outcomes you want to avoid. Join this highly interactive session to discuss ways to identify meaningful “verticals” of alerts for the greatest gains, as well as methods for studying the impact these approaches deliver. The discussion will cover a variety of drug domains, ranging from drug-drug interactions and drug-disease problems to geriatric precautions and allergies. Your participation is also your opportunity to impact the next set of enhancements to the FDB drug knowledge bases.

Oracle

Topic: Shared Accountability: How IT Will Engage Consumers on the Quality/Cost Equation

Speakers: Rob Fassett, MD, CMIO, Oracle Health Sciences Global Business Unit

Target Audience: CIOs, CMIOs and CTOs

In the rush to replace payers with providers as the new parameter in the quality/cost equation we often leave out the most important factor: patients. Patients ultimately represent the vast majority of the potential for improvement. Why not engage them early and often as we redesign accountable care pathways, quality metrics, reimbursement schemes, et cetera? Let’s make the functional unit of change, and accountability, the patient + provider team. In this session we will explore the means by which health systems are using IT tools to engage patients and gather them into the overall accountable care scheme.

  • Review the literature supporting patient accountability including brief synopsis of “top 10” articles
  • Overview of the role of IT will play enabling patients to accept accountability
  • Case study: patient activation through mobile analytics at the University of Louisville
  • A call to action: 7 things IT needs to do to help patients become part of the quality/cost solution

Wolters Kluwer Health

Topic: Practical Issues and Challenges in Implementing Clinical Decision Support for Pharmacogenomics

Speakers: Howard Strasberg, MD, MS; David Weinstein, RPh, PhD

Target Audience: Experts/researchers in CDS and/or pharmacogenomics

This focus group will explore various issues surrounding how to make pharmacogenomics clinical decision support available on a widespread basis. Topics will include genetic test result granularity (genotype vs phenotype), nomenclature for genotypes, nomenclature for phenotypes, test result message formats, preemptive alerts, and specific recommendations regarding testing, treatment, education, medication dosing and therapeutic alternatives.

To register, complete the form below. There is no additional fee to attend a roundtable, however you must register to be considered. Only registered Annual Symposium attendees may register.